Publication | Open Access

New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease

Alzheimer's DiseaseMedicineDementiaAmyloid DepositionAnimal ModelsNeuropharmacologyNeurofibrillary DegenerationNeurochemical BiomarkersNeuroprotectionNeuroscienceNeurologyNeurodegenerationPharmacologyTreatment